Santen EMEA announces RWD on Taptiqom
Taptiqom was efficient in patients with insufficiently controlled open-angle glaucoma (OAG) and ocular hypertension (OHT).
Read More
Tag: RWD
Cegedim, Sanofi enter healthcare improvement RWD collaboration
The company will provide Sanofi with information going back to 1994.
Read More
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
